Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Yuya Yoshizawa"'
Autor:
Kentaro Semba, Miwa Tanaka, Naomi Tamaki, Yuya Yoshizawa, Takao Yamori, Shin Ichi Yaguchi, Takuro Nakamura, Kanami Yamazaki, Nachi Namatame, Shingo Dan, Mutsumi Okamura, Yumiko Nishimura
Publikováno v:
Oncotarget
Treatment of patients with advanced sarcoma remains challenging due to lack of effective medicine, with the development of novel drugs being of keen interest. A pan-PI3K inhibitor, ZSTK474, has been evaluated in clinical trials against a range of adv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e71c5688eff6eb9544143f6a9fa52e16
https://doi.org/10.18632/oncotarget.26216
https://doi.org/10.18632/oncotarget.26216
Autor:
Naomi Tamaki, Kanami Yamazaki, Yumiko Nishimura, Yuya Yoshizawa, Shingo Dan, Shinichi Yaguchi, Nachi Namatame, Mutsumi Okamura
Publikováno v:
Cancer Research. 79:3909-3909
Phosphatidylinositol-3 kinase (PI3K) is a key signaling molecule for tumor growth and survival, thus the PI3K pathway has been thought to be a promising target for cancer therapy. We previously identified a novel phosphatidylinositol-3 kinase (PI3K)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64b963ee26f9cc6d64f285923980bcfa
https://doi.org/10.1158/1538-7445.am2019-3909
https://doi.org/10.1158/1538-7445.am2019-3909